Therefore, in the present work, we investigated changes in synaptic insulin responsiveness in the hippocampus after TBI in relation to an increased risk to AD pathology-driven synaptic dysfunction and protection by insulin treatment. The gene discussed is INS; the disease is Alzheimer disease.